Home › Targets › ActRIIB

ActRIIB (1 companies · 2 programs)

Companies with an active program directed at ActRIIB.

Keros Therapeutics, Inc. KROS

rinvatercept — Duchenne Muscular Dystrophy Phase 2
rinvatercept — Amyotrophic Lateral Sclerosis Phase 1